Phio Pharmaceuticals Corp (PHIO) has fallen 26.54% Thursday In Premarket Trading

Phio Pharmaceuticals Corp (PHIO) has fallen Thursday morning, with the stock declining -26.54% in pre-market trading to 1.91. PHIO's short-term technical score of 64 indicates that the stock has traded more bullishly over the last month than 64% of stocks on the market. In the Biotechnology industry, which ranks 136 out of 146 industries, PHIO ranks higher than 84% of stocks. Phio Pharmaceuticals Corp has risen 18.72% over the past month, closing at $1.75 on September 14. During this period of time, the stock fell as low as $1.36 and as high as $1.85. PHIO has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.

PHIO has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on PHIO!

See Full PHIO Report

Phio Pharmaceuticals Corp has a Long-Term Technical rank of 58. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 42% of the market scoring higher. In the Biotechnology industry which is number 138 by this metric, PHIO ranks better than 138% of stocks.

Important Dates for Investors in PHIO:

-Phio Pharmaceuticals Corp is set to release earnings on 2023-11-09. Over the last 12 months, the company has reported EPS of $-14.34. -We do not have a set dividend date for Phio Pharmaceuticals Corp at this time. Click Here To Get The Full Report on Phio Pharmaceuticals Corp (PHIO)